TK

Tamara K.

VP Global Medical Affairs And Clinical Development at Partex

Tamara K. currently serves as VP of Global Medical Affairs and Clinical Development at Partex since April 2024. Previously, Tamara held the position of Head of Medical Affairs Regional at Idorsia Pharmaceuticals Ltd, leading the tactical plan for the pre-launch and launch of daridorexant, engaging meaningfully with key opinion leaders (KOLs) and fostering team development. Prior roles include Sr. Global Medical Director at Roche, Chief Medical Officer at Phoenixus AG, and Medical Director at Novartis, where Tamara managed clinical trials and collaborated on global strategy. Additional experience includes Clinical Lead IQOS at Philip Morris International, Senior Clinical Research Scientist at Boehringer Ingelheim, and co-founding Silicon Dominion as VP of Medical Affairs. Educational background includes an MBA from the University of Pittsburgh Katz Graduate School of Business and a Medical Doctor degree from Novosibirsk State Medical University.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


P

Partex

Partex NV is ​the first digital ​pharma platform that is set to be the largest AI-powered Drug Assets Manager. With the power of AI at its core, we at Partex NV Group deliver faster, lower-cost healthcare innovations, validated by wet-lab and real-world evidence. Our pioneering digital platform enables smarter decision-making throughout the entire value chain. What sets us ​apart: ​- Within the Partex ​ecosystem, patients ​​keep ownership of ​their data and they are rewarded for ​participating in research projects - ​Our ​AI/ML algorithms enable key ​industry players to develop life-saving drugs while also developing our own drug assets - A ​strong history of success and ​performance: from humble software beginnings to a ​fully-fledged platform with over ​250 employees in 3 continents Our vision is to transform the ​Life science Industry​ by curing incurable diseases and increasing humanity's longevity. We dare to care! ​We have a global presence that extends from ​APAC to ​the Americas, with offices currently in India, Germany, Switzerland and ​USA. CEO & Co-Founder: Dr. Gunjan Bhardwaj Chairman & Co-Founder: Francisco Fernandez Companies belonging to Partex group: www.innoplexus.com www.cureteq.com www.perpetualblock.io www.amrit.ai www.assay.works


Headquarters

Eschborn, Germany

Employees

201-500

Links